UNITY Biotechnology, Inc. to Host Investor & Analyst Event on Cellular Senescence
November 13, 2018 08:00 ET
|
Unity Biotechnology, Inc.
- Event will be webcast live - SAN FRANCISCO, Nov. 13, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend...
UNITY Biotechnology, Inc. Reports Third Quarter 2018 Financial Results
November 07, 2018 16:05 ET
|
Unity Biotechnology, Inc.
SAN FRANCISCO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY Biotechnology, Inc. to Announce Third Quarter 2018 Financial Results
October 31, 2018 16:05 ET
|
Unity Biotechnology, Inc.
SAN FRANCISCO, Oct. 31, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY Biotechnology, Inc. to Participate in the Cantor Fitzgerald Annual Global Healthcare Conference
September 24, 2018 16:05 ET
|
Unity Biotechnology, Inc.
SAN FRANCISCO, Sept. 24, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY Biotechnology, Inc. to Participate in the Morgan Stanley 16th Annual Global Healthcare Conference
September 05, 2018 16:05 ET
|
Unity Biotechnology, Inc.
SAN FRANCISCO, Sept. 05, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY Biotechnology, Inc. Reports Second Quarter 2018 Financial Results
August 09, 2018 16:05 ET
|
Unity Biotechnology, Inc.
SAN FRANCISCO, Aug. 09, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY Biotechnology, Inc. to Announce Second Quarter 2018 Financial Results
July 31, 2018 16:05 ET
|
Unity Biotechnology, Inc.
SAN FRANCISCO, Calif., July 31, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY Biotechnology, Inc. Announces First Patient Treated in UBX0101 Phase 1 Trial for Osteoarthritis of the Knee
June 25, 2018 08:00 ET
|
Unity Biotechnology, Inc.
SAN FRANCISCO, June 25, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY Biotechnology, Inc. Added to Russell 3000®, 2000® and MicroCap® Indexes
June 13, 2018 16:00 ET
|
Unity Biotechnology, Inc.
SAN FRANCISCO, June 13, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY Biotechnology, Inc. Reports First Quarter 2018 Financial Results
June 07, 2018 17:00 ET
|
Unity Biotechnology, Inc.
SAN FRANCISCO, June 07, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...